EUS – Fine- Needle Aspiration Biopsy (FNAB) in the Diagnosis of Pancreatic Adenocarcinoma: A Review

1. RAUT CP, GRAU AM, STAERKEL GA, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg. 2003; 7(1):118-28.10.1016/S1091-255X(02)00150-6Search in Google Scholar

2. ELOUBEIDI MA, CHEN VK, ISAM A, ELTOUM IA, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. The American Journal of Gastroenterology .2003; 98:2663-8.10.1016/S0002-9270(03)01699-XSearch in Google Scholar

3. HAREWOOD G, WIERSEMA MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. The American Journal of Gastroenterology.2002; 97: 1386-91.10.1111/j.1572-0241.2002.05777.xSearch in Google Scholar

4. YLAGAN LR, EDMUNDOWICZ S, KASAL K, et al. Endoscopic ultrasound guided fine-needle aspiration cytology of pancreatic carcinoma. A 3-year experience and review of the literature. Cancer Cytopathology. 2002; 96(6):362-9.10.1002/cncr.10759Search in Google Scholar

5. FRITSCHER-RAVENS A, IZBICKI JB, SRIRAM VJP, et al. Endosonography-guided, fine-needle aspiration cytology extending the indication for organ-preserving pancreatic surgery. The American Journal of Gastroenterology.2000; 95:2255-60.10.1111/j.1572-0241.2000.02311.xSearch in Google Scholar

6. AFIFY AM, AL-KHAFAJI BM, KIM B, SCHEIMAN JM et al. Endoscopic ultrasound-guided fine needle aspiration of the pancreas. Diagnostic utility and accuracy. Acta Cytologica. 2003: 47(3):341-8.10.1159/000326531Search in Google Scholar

7. MICHAEL JONATHAN HEWITT, MCPHAIL, MRCP, LUCIA POSSAMAI, AMEET DHAR, PANAGIOTIS VLAVIANOS,, KEVIN J. MONAHAN. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointestinal Endoscopy.2012; 75(2):319-31.10.1016/j.gie.2011.08.049Search in Google Scholar

8. DEMAY RM. The art and science of cytopathology: pancreas. Chicago: ASCP Press. 1996: 1059-69.Search in Google Scholar

9. NIEDERHUBER JE, MURRAY F. BRENNAN, HERMAN R. MENCK . The national cancer data base report on pancreatic cancer. Cancer. 1995; 76 (9): 1671-77.10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-RSearch in Google Scholar

10. BECKINGHAM IJ. ABC of liver, pancreas and gallbladder, 1st ed. London: BMJ: 2001.Search in Google Scholar

11. GREENBLATT DY, KELLY KJ, RAJAMANICKAM V. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Annals of Surgical Oncology. 2011; 18(8):2126-35.10.1245/s10434-011-1594-6Search in Google Scholar

12. NOH KW, WALLACE MB. Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic adenocarcinoma. MedGenMed. 2005; 7(2): 15- 19.Search in Google Scholar

13. BRET PM, VIVIANE NICOLET V, LABADIE M. Percutaneous fine-needle aspiration biopsy of the pancreas. Diagnostic Cytopathology.1986; 2(3):221-7.10.1002/dc.2840020309Search in Google Scholar

14. BRANDT KR, CHARBONEAU JW, STEPHENS DH, et al. CT- and US-guided biopsy of the pancreas. Radiology. 1993; 187: 99-104.10.1148/radiology.187.1.8451443Search in Google Scholar

15. LEE JG, LEUNG J. Tissue sampling at ERCP in suspected pancreatic cancer. Gastrointestinal Endoscopy Clinics of North America. 1998; 8(1):221-35.Search in Google Scholar

16. PAQUIN SC, GARIÉPY G, LEPANTO L, et al. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc. 2005 Apr; 61(4):610-1.10.1016/S0016-5107(05)00082-9Search in Google Scholar

17. MITCHELL ML, CARNEY CN. Cytologic criteria for the diagnosis of pancreatic carcinoma. American Journal of Clinical Pathology. 1985; 83(2):171-6.10.1093/ajcp/83.2.1712982255Search in Google Scholar

18. COHEN MB, EGERTER DP, HOLLY EA, AHN DK, MILLER TR. Pancreatic adenocarcinoma: Regression analysis to identify improved cytologic criteria. Diagnostic Cytopathology.1991; 7(4):341-5.10.1002/dc.28400704041935510Search in Google Scholar

19. ROBINS DB, KATZ RL, EVANS DB, ATKINSON EN, GREEN L. Fine needle aspiration of the pancreas. In quest of accuracy. Acta Cytologica. 1995; 39(1):1-10.Search in Google Scholar

20. FEKETE PS, NUNEZ C, DEBORAH A. PITLIK DA. Fine-needle aspiration biopsy of the pancreas: A study of 61 cases. Diagnostic Cytopathology. 1986; 2(4):301-6.10.1002/dc.28400204073792189Search in Google Scholar

21. AL-KAISI N, SIEGLER EE. Fine needle aspiration cytology of the pancreas. Acta Cytologica. 1989; 33(2):145-52.Search in Google Scholar

22. KOCJAN G, RODE J, LEES WR. Percutaneous fine needle aspiration cytology of the pancreas: advantages and pitfalls. J Clin Pathol 1989; 42:341-7.10.1136/jcp.42.4.34111419032541174Search in Google Scholar

23. BRITS CJ, FRANZ RC. Pale nodular nuclei-diagnostic of adenocarcinoma of the pancreas? Acta Cytologica. 1976; 20(5):462-8.Search in Google Scholar

24. LIN F, STAERKEL GM. Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimens. Cancer Cytopathology. 2003; 99(1):44-50.10.1002/cncr.1101212589645Search in Google Scholar

25. LIN F, JIANHUI S, HAIYAN L, et al. Diagnostic utility of S100P and von Hippel-Lindau Gene Product (pVHL) in pancreatic adenocarcinoma - with implication of their roles in early tumorigenesis. American Journal of Surgical Pathology. 2008; 32(1):78-91.10.1097/PAS.0b013e31815701d118162774Search in Google Scholar

26. LEVY M, LIN F, XU H, DHALL D, BETSY O. SPAULDING BO, WANG HL. S100P, von Hippel-Lindau gene product and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Human Pathology. 2010; 41(9):1210-1219.10.1016/j.humpath.2010.01.01420382408Search in Google Scholar

27. ZHAO H, MANDICH D , RICHARD W. CARTUN RW, LIGATO S. Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagnostic Cytopathology.2007; 35(11):700-4.10.1002/dc.2073917924416Search in Google Scholar

28. KYOKO K, NOBUYUKI O, SEISHIRO M, MASASHI S, MANABU T, TOSHIO M. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas. Hepatobiliary Pancreat Dis Int. 2008; 7(1):86-90.Search in Google Scholar

29. AGARWAL B, LUDWIG, OJ, BRIAN T. COLLINS BT, CORTESE C. Immunostaining as an adjunct to cytology for diagnosis of pancreatic adenocarcinoma. Clinical Gastroenterology and Hepatology. 2008; 6(12):1425-1431.10.1016/j.cgh.2008.08.01019081530Search in Google Scholar

30. MCCARTHY DM, MAITRA A; ARGANI P, et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: Mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Applied Immunohistochemistry & Molecular Morphology. 2003; 11(3):238-43.Search in Google Scholar

31. HASSAN R, LASZIK ZG, MEGAN LERNER M, RAFFELD M, POSTIER R, BRACKETT D. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis. American Journal of Clinical Pathology.2005; 124: 838-845.10.1309/F1B64CL7H8VJKEAFSearch in Google Scholar

32. KARANJAWALA ZE, ILLEI PB, ASHFAQ R, et al. New markers of pancreatic cancer identified through differential gene expression analyses: Claudin 18 and Annexin A8. Am J Surg Pathol. 2008; 32(2): 188-196.10.1097/PAS.0b013e31815701f3267881118223320Search in Google Scholar

33. DE LOTT LB, MORRISON C, SUSTER S, COHN DE, FRANKEL WL. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. Arch Pathol Lab Med. 2005; 129(9):1100-5.10.5858/2005-129-1100-CIAUMO16119980Search in Google Scholar

34. GOLDSTEIN NS, BASSI D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Am J Clin Pathol. 2001; 115(5):695-702.10.1309/1NCM-46QX-3B5T-7XHR11345833Search in Google Scholar

35. CHU PG, SCHWARZ RE, LAU, SK, YEN Y, WEISS L. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of vater adenocarcinoma: Application of CDX2, CK17, MUC1, and MUC2. American Journal of Surgical Pathology. 2005; 29(3):359-367. 10.1097/01.pas.0000149708.12335.6a15725805Search in Google Scholar

36. LAU SK, PRAKASH S, GELLER SA, ALSABEH R. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Human Pathology 2002; 33(12):1175-1181.10.1053/hupa.2002.13010412514785Search in Google Scholar

37. KOHJI NAGATA, MICHIKO HORINOUCHI, MIYUKI SAITOU, et al. Mucin expression profile in pancreatic cancer and the precursor lesions. Journal of Hepato-Biliary-Pancreatic Surgery.2007; 14(3):243-254.10.1007/s00534-006-1169-217520199Search in Google Scholar

38. NIRAG JHALA, DARSHANA JHALA, SELWYN M. VICKERS, et al. Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates: A translational research application. American Journal of Clinical Pathology. 2006: 126:572-9.10.1309/CEV30BE088CBDQD9Search in Google Scholar

39. TAMAR A. GIORGADZE, HEATHER PETERMAN, ZUBAIR BALOCH, et al. Diagnostic utility of mucin profile in fineneedle aspiration specimens of the pancreas: An immunohistochemical study with surgical pathology correlation. Cancer Cytopathology. 2006; 108(3):186-197.10.1002/cncr.2191316628655Search in Google Scholar

40. KOSARAC O, TAKEI H, ZHAI QJ, SCHWARTZ MR, MODY DR. S100P and XIAP expression in pancreatic ductal adenocarcinoma: Potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology. Acta Cytologica 2011; 55: 142-148.10.1159/00032091321325798Search in Google Scholar

41. WACHTER DL, SCHLABRAKOWSKI A, HOEGEL J, KRISTIANSEN G, HARTMANN A, RIENER MO. Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma. American Journal of Surgical Pathology. 2011; 35(6):873-877.10.1097/PAS.0b013e318218922321566520Search in Google Scholar

42. LIU H, SHI J, ANANDAN V, WANG HL, DIEHL D, BLANSFIELD J, GERHARD G, LIN F. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas. Arch Pathol Lab Med. 2012;136(6):601-9.10.5858/arpa.2011-0326-OA22646265Search in Google Scholar

43. DANIEL C. DIM , FENG JIANG, QI QIU, TING, PETER DARWIN, WILLIAM H. RODGERS, HONG QI PENG. The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration. Diagnostic Cytopathology 2014; 42(3):193-9.10.1002/dc.2168421538952Search in Google Scholar

44. TAKAHASHI K, YAMAO K, OKUBO K et al. Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA. Gastrointest. Endosc. 2005; 61: 76-9.Search in Google Scholar

45. HOSODA W, TAKAGI T, MIZUNO N et.al. Diagnostic approach to pancreatic tumor with the specimens of endoscopic ultrasound-guided fine needle aspiration. Pathol. Int. 2010; 60: 358-64.Search in Google Scholar

46. DENG H, SHI J, WILKERSON M, FUPREE W, LIN F. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine needle aspiration biopsy specimens. Am. J. Clin. Pathol. 2008; 129: 81-8.Search in Google Scholar

47. GIORGADZE TA, PETERMAN H, BALOCH ZW et al. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas. Cancer Cytopathol. 2006; 108: 186-97.10.1002/cncr.2191316628655Search in Google Scholar

48. KROEP JR, LOVES WJ, VAN DER WILT CL et al. Pretreatment deoxycytidine linase levels predict in vivo gemcitabine sensitivity. Mol. Cancer Ther. 2002; 1: 371-6.Search in Google Scholar

49. ASHIDA R, NAKATA B, SHIGEKAWA M et al. Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasoundguided fine-needle aspiration biopsy of unresectable pancreatic cancer. J. Exp. Clin. Cancer Res. 2009; 28: 83.Search in Google Scholar

50. GIOVANNETTI E, DEL TACCA M, MEY V et al. Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res. 2006; 66: 3928-35.10.1158/0008-5472.CAN-05-420316585222Search in Google Scholar

51. FUJITA H, OHUCHIDA K, MIZUMOTO K et al. Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia 2010; 12: 807-10.10.1593/neo.10458295033020927319Search in Google Scholar

52. YOSHINAGA S, SUZUKI H, ODA I, SAITO Y. Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc. 2011; 23 Suppl 1:29-33. 10.1111/j.1443-1661.2011.01112.x21535197Search in Google Scholar